Cell Therapy Manufacturing Market to Reach USD 24.18 Billion by 2034, Fueled by Growth in Regenerative Medicine and Advancements in ATMP Production
The global cell therapy manufacturing market is undergoing a transformative evolution, propelled by groundbreaking advances in regenerative medicine, increased clinical application of cell-based therapies, and expanding investment in advanced therapy medicinal products (ATMPs). Valued at USD 5.68 billion in 2024, the market is forecast to grow at a remarkable CAGR of...
0 Comments
0 Shares
French
Dutch